Cargando…

Preclinical Models of Brain Metastases in Breast Cancer

Breast cancer remains a leading cause of mortality among women worldwide. Brain metastases confer extremely poor prognosis due to a lack of understanding of their specific biology, unique physiologic and anatomic features of the brain, and limited treatment strategies. A major roadblock in advancing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Knier, Natasha N., Pellizzari, Sierra, Zhou, Jiangbing, Foster, Paula J., Parsyan, Armen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945440/ https://www.ncbi.nlm.nih.gov/pubmed/35327469 http://dx.doi.org/10.3390/biomedicines10030667

Ejemplares similares

Anticancer effects of radiation therapy combined with Polo-Like Kinase 4 (PLK4) inhibitor CFI-400945 in triple negative breast cancer
por: Parsyan, Armen, et al.
Publicado: (2021)

Preclinical and Clinical Efficacy of Trastuzumab Deruxtecan in Breast Cancer Brain Metastases
por: Kabraji, Sheheryar, et al.
Publicado: (2023)

Treatment of breast cancer brain metastases: radiotherapy and emerging preclinical approaches
por: Mampre, David, et al.
Publicado: (2022)

BSCI-04. TARGETING TRIPLE-NEGATIVE BREAST CANCER BRAIN METASTASES WITH A RE-ENGINEERED LUPUS AUTOANTIBODY
por: Zhang, Shenqi, et al.
Publicado: (2019)

On the Diversification of the Translation Apparatus across Eukaryotes
por: Hernández, Greco, et al.
Publicado: (2012)

Development and Preclinical Application of an Immunocompetent Transplant Model of Basal Breast Cancer with Lung, Liver and Brain Metastases
por: Aprelikova, Olga, et al.
Publicado: (2016)

Glial activation positron emission tomography imaging in radiation treatment of breast cancer brain metastases
por: Badiuk, Sawyer Rhae, et al.
Publicado: (2022)

P-glycoprotein mediated efflux limits substrate and drug uptake in a preclinical brain metastases of breast cancer model
por: Adkins, Chris E., et al.
Publicado: (2013)

Breast cancer brain metastases: the last frontier
por: Leone, José Pablo, et al.
Publicado: (2015)

Targeted Delivery of Secretory Promelittin via Novel Poly(lactone‐co‐β‐amino ester) Nanoparticles for Treatment of Breast Cancer Brain Metastases
por: Zhou, Yu, et al.
Publicado: (2020)

Racial disparities in breast cancer preclinical and clinical models
por: Clarke, Shannique, et al.
Publicado: (2022)

Mouse models of breast cancer in preclinical research
por: Park, Mi Kyung, et al.
Publicado: (2018)

Treatment strategies for breast cancer brain metastases
por: Bailleux, Caroline, et al.
Publicado: (2020)

What Is the Role of Interleukins in Breast Cancer Bone Metastases? A Systematic Review of Preclinical and Clinical Evidence
por: Salamanna, Francesca, et al.
Publicado: (2019)

Targeted Therapies for Brain Metastases from Breast Cancer
por: Venur, Vyshak Alva, et al.
Publicado: (2016)

Management of Brain and Leptomeningeal Metastases from Breast Cancer
por: Pellerino, Alessia, et al.
Publicado: (2020)

Salvage Treatment for Progressive Brain Metastases in Breast Cancer
por: Spałek, Mateusz Jacek, et al.
Publicado: (2022)

Breast cancer brain metastases: new directions in systemic therapy
por: Lin, Nancy U
Publicado: (2013)

Breast cancer brain metastases: biology and new clinical perspectives
por: Witzel, Isabell, et al.
Publicado: (2016)

Breast Cancer Brain Metastases: Clonal Evolution in Clinical Context
por: Saunus, Jodi M., et al.
Publicado: (2017)

A method for the efficient iron-labeling of patient-derived xenograft cells and cellular imaging validation
por: Knier, Natasha N., et al.
Publicado: (2021)

Management of solitary and multiple brain metastases from breast cancer
por: Willett, Addison, et al.
Publicado: (2015)

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)

Navigating the Blood–Brain Barrier: Challenges and Therapeutic Strategies in Breast Cancer Brain Metastases
por: Terceiro, Lucas E. L., et al.
Publicado: (2023)

THER-12. PRECLINICAL EVALUATION OF NERATINIB PLUS T-DM1 IN ORTHOTOPIC PDX MODELS OF HER2-POSITIVE BREAST CANCER BRAIN METASTASES
por: Ni, Jing, et al.
Publicado: (2019)

A Perspective on Cell Tracking with Magnetic Particle Imaging
por: Sehl, Olivia C., et al.
Publicado: (2020)

Anti-tumour activity of bisphosphonates in preclinical models of breast cancer
por: Holen, Ingunn, et al.
Publicado: (2010)

The management of elderly patients with brain metastases from breast cancer
por: Ruiz-Garcia, Henry, et al.
Publicado: (2020)

Preclinical Evaluation of Oncolytic Δγ (1)34.5 Herpes Simplex Virus Expressing Interleukin-12 for Therapy of Breast Cancer Brain Metastases
por: Cody, James J., et al.
Publicado: (2012)

Engineering Circulating Tumor Cells as Novel Cancer Theranostics
por: Parkins, Katie M, et al.
Publicado: (2020)

Therapy of breast cancer brain metastases: challenges, emerging treatments and perspectives
por: Kotecki, Nuria, et al.
Publicado: (2018)

Risk factors for breast cancer brain metastases: a systematic review
por: Koniali, Lola, et al.
Publicado: (2020)

Preclinical and clinical efficacy of trastuzumab-deruxtecan in breast cancer brain metastases: a new insight on central nervous system activity
por: Batista, Marta Vaz, et al.
Publicado: (2023)

Rationale for the Use of Upfront Whole Brain Irradiation in Patients with Brain Metastases from Breast Cancer
por: Tallet, Agnes V., et al.
Publicado: (2014)

Understanding Heterogeneity and Permeability of Brain Metastases in Murine Models of HER2-Positive Breast Cancer Through Magnetic Resonance Imaging: Implications for Detection and Therapy
por: Murrell, Donna H., et al.
Publicado: (2015)

Preclinical Models of Adrenocortical Cancer
por: Sedlack, Andrew J. H., et al.
Publicado: (2023)

Methods and results of local treatment of brain metastases in patients with breast cancer
por: Szadurska, Agnieszka, et al.
Publicado: (2017)

Liquid biopsy for brain metastases and leptomeningeal disease in patients with breast cancer
por: Morganti, Stefania, et al.
Publicado: (2023)

Local, multimodal intralesional therapy renders distant brain metastases susceptible to PD-L1 blockade in a preclinical model of triple-negative breast cancer
por: Yokoi, Toshihiro, et al.
Publicado: (2021)

Trastuzumab distribution in an in-vivo and in-vitro model of brain metastases of breast cancer
por: Terrell-Hall, Tori B., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3e14o5eeuvgda8dgble4sfhnbu